Amin Khan - 12 Jun 2023 Form 4 Insider Report for Icosavax, Inc.

Role
EVP, Head of Research & Dev.
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
12 Jun 2023
Net transactions value
$0
Form type
4
Filing time
14 Jun 2023, 19:48:46 UTC
Previous filing
08 Aug 2022
Next filing
20 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Award $0 +180,000 $0.000000 180,000 12 Jun 2023 Common Stock 180,000 $10.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest on June 12, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service through the applicable vesting date.